Active Ingredient History

NOW
  • Now
Methohexital is an ultrashort-acting barbiturate widely used in dentistry because of its rapid onset, predictable effects, and short duration of action. It was marked under the name brevital sodium for the intravenous anaesthesia. It has also been commonly used to induce deep sedation. Like other barbiturates, methohexital exerts its effects through the gamma-aminobutyric acid (GABA) receptor complex. By binding to its own receptor on the complex, methohexital augments the inhibitory effect of GABA on neurons and additionally can exert a similar effect independent of GABA.   NCATS

  • SMILES: CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O
  • InChIKey: NZXKDOXHBHYTKP-UHFFFAOYSA-N
  • Mol. Mass: 262.31
  • ALogP: 1.31
  • ChEMBL Molecules:
More Chemistry

Drug Pricing (per unit)

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

5-allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1h,3h,5h)-pyrimidinetrione | (+-)-5-allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid | 5-allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione | 5-allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid | alpha-dl-1-methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid | brevimytal | brevital | brevital sodium | brietal | brietal sod | enallynymall | enallynymal sodium | methodrexitone | methohexital | methohexital sodium | methohexitalum | methohexitone | metoesital | metohexital

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue